yingweiwo

Histone Demethylase

Histone Demethylase

Histone Demethylase related products

Structure Cat No. Product Name CAS No. Product Description
(1R,2S)-NCD38 TFA V56074 (1R,2S)-NCD38 TFA 2078047-42-2 (1R,2S)-NCD38 TFA is an enantiomer of NCD38 TFA.
8-羟基喹啉-5-羧酸 V0372 IOX1 5852-78-8 IOX1 (5-Carboxy-8-hydroxyquinoline) is a novel, potent and broad-spectrum inhibitor of 2OG oxygenases (e.
Acaricide V94227 Acaricide The acaricide (compound 7l) is a potent LSD1 inhibitor.
Acaricide agent 1 V128069 Acaricide agent 1 Acaricide agent 1 is a potent LSD1 inhibitor.
AS8351 V2982 AS8351 796-42-9 AS8351 is a potent inhibitor of KDM5B (lysine-specific histone demethylase 5B) which plays an important role in maintaining cancer stem cells and justifies the rationale for studying the effects of continuous inhibition of this epigenetic factor in cancer.
CBB1007 hydrochloride V56067 CBB1007 hydrochloride 2070014-96-7 CBB1007 HCl is a highly efficient substrate competitive, reversible, and selective inhibitor of the histone demethylase LSD1, with IC50 of 5.27 uM for hLSD1.
CPI-455 V2606 CPI-455 1628208-23-0 CPI-455 is a novel, potent andspecific inhibitor of the KDM5demethylase which catalyzes the demethylation of histone H3 on lysine 4 (H3K4) and is required for the survival of drug-tolerant persister cancer cells (DTPs).
DDP-38003 dihydrochloride V2936 DDP-38003 dihydrochloride 1831167-98-6 DDP-38003 dihydrochloride, atranylcypromine (TCPA) derivative, is a novel, potent and orally bioavailable inhibitor of histone lysine-specific demethylase 1A (KDM1A/LSD1).
DDP-38003 trihydrochloride V77096 DDP-38003 trihydrochloride DDP-38003 triHCl is a novel, orally bioactive KDM1A/LSD1 inhibitor (antagonist) with IC50 of 84 nM.
GSK 690 Hydrochloride V52030 GSK 690 Hydrochloride 2436760-79-9 GSK 690 ( HCl) is a reversible inhibitor of lysine-specific demethylase 1 (LSD1) with a Kd of 9 nM and IC50 of 37 nM.
GSK J4 HCl V4761 GSK J4 HCl 1797983-09-5 GSK J4 (GSK-J4) is a novel,cell permeable, and potent prodrug of GSK J1 with anti-inflammatory effects.
GSK-690 HCl V45816 GSK-690 HCl GSK-690 hydrochloride is a selective reversible inhibitor of lysine specific demethylase 1(LSD1) with anticancer activity.
GSK-J4 V2660 GSK-J4 1373423-53-0 GSK J4 is a novel,cell permeable, and potent prodrug of GSK J1, which is the first selective inhibitor of the H3K27 histone demethylase (KDM) JMJD3 and UTX with IC50 of 60 nM in a cell-free assay and is inactive against a panel of demethylases of the JMJ family.
GSK-LSD1 dihydrochloride V52029 GSK-LSD1 dihydrochloride 2102933-95-7 GSK-LSD1 diHCl is a potent, selective, irreversible inhibitor of lysine-specific demethylase (LSD1) with IC50 of 16 nM.
GSK2807 TFA V4128 GSK2807 TFA 2245255-66-5 GSK2807 TFA (GSK-2807 TFA), the trifluoroacetic acid salt form ofGSK2807, is a selective and SAM-competitiveSMYD3inhibitorwith potential antitumor activity.
JIB 04 V0371 JIB-04 (NSC-693627) 199596-05-9 JIB-04 (also known as NSC693627) is anovel, potent and pan-selective inhibitor of Jumonji histone demethylase (JMJD) inhibitor with antineoplastic activity.
JNJ-9350 V51918 JNJ-9350 326923-09-5 JNJ-9350 is an inhibitor (blocker/antagonist) of spermine oxidase (SMOX) with IC50 of 0.01 μM.
KDOAM-25 trihydrochloride V80481 KDOAM-25 trihydrochloride KDOAM-25 tri HCl is a potent and selective inhibitor of histone lysine demethylase 5 (KDM5), with IC50s of 71 nM, 19 nM, 69 nM, and 69 nM for KDM5A, KDM5B, KDM5C, and KDM5D respectively.
LSD1-IN-30 V85462 LSD1-IN-30 1289575-45-6
LSD1-IN-43 V139086 LSD1-IN-43 LSD1-IN-43 is a highly selective, reversible, orally effective LSD1 inhibitor that can cross the blood-brain barrier, with an IC50 value of 0.8 μM.
Contact Us